1 | 00201600 | - | - | - | - | 1件: 229 229 |
2 | Blood collection | - | - | - | - | 2件: 229 229, 271 |
3 | Bronchoalveolar lavage fluid collection | - | - | - | - | 1件: 229 229 |
4 | Centricyte 1000 | - | - | - | - | 2件: 85 85, 229 |
5 | Diagnostic Test: Abdominal and liver ultrasound. | - | - | - | - | 1件: 229 229 |
6 | Diagnostic Test: Brain MRI | - | - | - | - | 2件: 25 25, 229 |
7 | Diagnostic Test: Methionine/homocysteine Dosage | 2件: Homocysteine Homocysteine, Methionine | 2件: D00019
D00019
,
D04983
| - | - | 1件: 229 229 |
8 | Diagnostic Test: Thoracic CT scan | - | - | - | - | 1件: 229 229 |
9 | GM-CSF | - | - | - | - | 3件: 51 51, 60, 229 |
10 | GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim) | 1件: Sargramostim Sargramostim | 1件: D05803
D05803
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
11 | GM-CSF [Leukine (Sargramostim)] | 1件: Sargramostim Sargramostim | 1件: D05803
D05803
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
12 | GM-CSF inhalation therapy | - | - | - | - | 1件: 229 229 |
13 | Granulocyte-macrophage colony stimulating factor (GM-CSF) | - | - | - | - | 1件: 229 229 |
14 | Homocysteine | 1件: Homocysteine Homocysteine | - | - | - | 1件: 229 229 |
15 | IV Deployment Of cSVF In Sterile Normal Saline IV Solution | - | - | - | - | 2件: 85 85, 229 |
16 | Leukine | 1件: Sargramostim Sargramostim | 1件: D05803
D05803
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
17 | Liberase Enzyme (Roche) | - | - | - | - | 2件: 85 85, 229 |
18 | Methionine | 1件: Methionine Methionine | 2件: D00019
D00019
,
D04983
| - | - | 7件: 34 34, 75, 84, 93, 229, 298, 300 |
19 | Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF) | - | - | - | - | 2件: 85 85, 229 |
20 | Molgramostim | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 3件: 97 97, 229, 299 |
21 | Molgramostim 300 mcg nebuliser solution | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
22 | Molgramostim 300 µg nebulizer solution | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
23 | Molgramostim Nebuliser solution 300 mcg | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
24 | Pioglitazone | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
25 | RhGM-CSF | 1件: Regramostim Regramostim | 1件: D05712
D05712
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
26 | Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件: 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
27 | Sargramostim | 1件: Sargramostim Sargramostim | 1件: D05803
D05803
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 7件: 6 6, 28, 60, 62, 96, 229, 285 |
28 | Sterile Normal Saline for Intravenous Use | - | - | - | - | 2件: 85 85, 229 |
29 | Vitamin B12 | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 4件: 6 6, 201, 229, 299 |
30 | Vitamin B12, B9, B6, C supplementation | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 1件: 229 229 |
31 | Whole Lung Lavage(WLL) | - | - | - | - | 1件: 229 229 |
32 | WLL | - | - | - | - | 1件: 229 229 |